Finally, we assessed TREM1 expression in relation to these markers, confirming its co-localization with the myeloid markers CD68 and CD15. The TREM1-positive spots were frequently located in close spatial proximity to CD8+ T cells and tumor regions. Here, CD8A is linked to neoplasm.